Literature DB >> 19009275

Adaptation of the hepatitis C virus to cell culture.

Artur Kaul1, Ilka Wörz, Ralf Bartenschlager.   

Abstract

A major breakthrough in the field of HCV research was the development of a system that supports the production of infectious virus particles. The key to this achievement was the molecular cloning of a genotype 2a genome, designated JFH1, which replicates to exceptionally high levels and at the same time supports virus particle assembly and release. A major drawback of this system was, however, the rather low yield of infectious particles obtained with the JFH1 genome as well as with most JFH1-derived virus chimeras. One approach to overcoming this hurdle is adaptation of the HCV genomes to cell culture. We found that both JFH1 and all chimeras, except one, can easily be adapted to cultured cells, increasing virus yields by up to three orders of magnitude. Surprisingly, adaptation is achieved by a multitude of mutations residing in both the structural and the nonstructural proteins. We therefore argue that a complex interaction between structural proteins and the HCV replicase takes place to allow efficient virus particle production.

Entities:  

Mesh:

Year:  2009        PMID: 19009275     DOI: 10.1007/978-1-59745-394-3_27

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  7 in total

1.  Novel mutations in a tissue culture-adapted hepatitis C virus strain improve infectious-virus stability and markedly enhance infection kinetics.

Authors:  Maria V Pokrovskii; Caroline O Bush; Rudolf K F Beran; Margaret F Robinson; Guofeng Cheng; Neeraj Tirunagari; Martijn Fenaux; Andrew E Greenstein; Weidong Zhong; William E Delaney; Matthew S Paulson
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

2.  The bioactive lipid 4-hydroxyphenyl retinamide inhibits flavivirus replication.

Authors:  Margot Carocci; Stephen M Hinshaw; Mary A Rodgers; Valerie A Villareal; Dominique J Burri; Rajendra Pilankatta; Natalya P Maharaj; Michaela U Gack; Eric J Stavale; Kelly L Warfield; Priscilla L Yang
Journal:  Antimicrob Agents Chemother       Date:  2014-10-13       Impact factor: 5.191

3.  Hepatitis C virus infection of neuroepithelioma cell lines.

Authors:  Nicola F Fletcher; Jian Ping Yang; Michelle J Farquhar; Ke Hu; Christopher Davis; Qiuchen He; Kimberly Dowd; Stuart C Ray; Sophie E Krieger; Johan Neyts; Thomas F Baumert; Peter Balfe; Jane A McKeating; Flossie Wong-Staal
Journal:  Gastroenterology       Date:  2010-06-09       Impact factor: 22.682

4.  Structural and functional studies of nonstructural protein 2 of the hepatitis C virus reveal its key role as organizer of virion assembly.

Authors:  Vlastimil Jirasko; Roland Montserret; Ji Young Lee; Jérôme Gouttenoire; Darius Moradpour; Francois Penin; Ralf Bartenschlager
Journal:  PLoS Pathog       Date:  2010-12-16       Impact factor: 6.823

5.  A Novel Genetic Group of Bovine Hepacivirus in Archival Serum Samples from Brazilian Cattle.

Authors:  Cláudio W Canal; Matheus N Weber; Samuel P Cibulski; Mariana S Silva; Daniela E Puhl; Hanspeter Stalder; Ernst Peterhans
Journal:  Biomed Res Int       Date:  2017-08-20       Impact factor: 3.411

6.  SuPReMe: a rapid reverse genetics method to generate clonal populations of recombinant RNA viruses.

Authors:  Jean-Sélim Driouich; Souand Mohamed Ali; Abdennour Amroun; Fabien Aubry; Xavier de Lamballerie; Antoine Nougairède
Journal:  Emerg Microbes Infect       Date:  2018-03-21       Impact factor: 7.163

Review 7.  Innovation and trends in the development and approval of antiviral medicines: 1987-2017 and beyond.

Authors:  Shuvam Chaudhuri; Julian A Symons; Jerome Deval
Journal:  Antiviral Res       Date:  2018-05-15       Impact factor: 5.970

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.